| AngioDynamics designs, manufactures and sells a range of medical, surgical and diagnostic devices used by healthcare providers. Co.'s product offerings fall within three Global Business Units: Endovascular Therapies, which supports the medical areas of thrombus management, Atherectomy, peripheral products and venous insufficiency; Oncology/Surgery, which provides a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation technology; and Vascular Access, which includes a range of peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters and related accessories and supplies. We show 48 historical shares outstanding datapoints in our coverage of ANGO's shares outstanding history.|
Understanding the changing numbers of ANGO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ANGO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ANGO by allowing them to research ANGO shares outstanding history
as well as any other stock in our coverage universe.